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ABSTRACT 
 
BACKGROUND: Penile erection is a hemodynamic process involving increased arterial inflow and 
restricted venous outflow, coordinated with corpus cavernosum and penile arterial smooth muscle 
relaxation. Any problem in this mechanism results in Erectile Dysfunction and its etiology is generally 
multifactorial. This study is aimed at determining the objective outcome of aerobic training in the 
management of Erectile Dysfunction of arterogenic origin using Meta analysis. 
METHODS:  Relevant publications were searched up to November 2010 in the MEDLINE (PubMed) 
database. The citation lists of randomized controlled trials on the effect of aerobic training and Erectile 
Dysfunction management using the International Index of Erectile Function (IIEF) as treatment 
outcome measure. Studies on different operative techniques on the effects of aerobic training for men 
with Erectile Dysfunction due to arterogenic Erecile Dysfunction were selected. Data on participants’ 
characteristics, study quality, population, intervention, treatment outcome were collected and analyzed. 
RESULTS: There were 5 randomized controlled studies using the International Index of Erectile 
Function as measure of treatment outcome. A total of 385 subjects were involved in 5 studies; results 
indicated significant effect of aerobic training on Erecile Dysfunction (t=5.856, p= .000) at p< 0.05.  
CONCLUSION: Subjects with arterogenic Erectile Dysfunction might benefit from aerobic training. 
More randomized controlled studies in this area are warranted 
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INTRODUCTION 
Male erectile dysfunction (ED) has been defined 
as the persistent inability to attain and/or maintain 
an erection sufficient for sexual performance (1). 
ED is very common, and its prevalence as well as 
severity increases with age (2). It has been 
recognized that the major cause of ED is 
atherosclerosis affecting the pelvic vasculature (3). 
The presence of ED has been known to predict 
future cardiovascular disease, and early detection 
may allow timely modification of remediable risk 
factors, or lead to the diagnosis of occult 
cardiovascular disease (4, 5).  
Penile erection is a hemodynamic process 
involving increased arterial inflow and restricted 
venous outflow, coordinated with corpus 
cavernosum and penile arterial smooth muscle 
relaxation. Any problem in this mechanism results 
in ED, and its etiology is generally multifactorial 
(6). Diabetes, hypertension, high serum 
cholesterol level, peripheral vascular disease and 
cardiac problems are significantly found together 
with ED (7). However, vascular reasons 
predominate in the etiology of ED and it 
frequently appears along with atherosclerosis (7). 
It is known that atherosclerotic lesions prevent 
blood flow into cavernosal tissues resulting in ED 
(8).  
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The endothelium is vital to the maintenance of 
vascular health. It is a critical determinant of 
vascular tone and patency, reactivity, 
inflammation, vascular remodeling, and blood 
fluidity. (9, 10). Nitric oxide (NO) is the most 
potent vasodilator and is secreted by the 
endothelium. It is synthesized from Larginine by 
the endothelial enzyme NO synthase (eNOS). NO 
released in response to sexual stimulation relaxes 
penile vascular smooth muscle by increasing 
intracellular cyclic 3', 5'-guanosine 
monophosphate (cGMP) concentration. 
Vasodilatation of erectile tissues allows the 
sinusoidal spaces to fill with blood resulting in the 
attainment and maintenance of an erection (5).     
 
Erection is a complex physiological process 
in which vascular factors play a pre-eminent role. 
Therapeutic options for men with arteriogenic 
erectile dysfunction (ED) are mainly 
administration of phosphodiesterase type 5 
inhibitors, intracavernous injections of vasoactive 
agents (for example, prostaglandin El, 
papaverine/phentolamine, or triple drug), 
intraurethral administration of prostaglandin El, 
and administration of centrally acting drugs (11, 
12). However, all of these methods circumvent the 
patient’s problem temporarily, and patients are not 
cured of impotence, they will remain dependent on 
these treatments for the remainder of their 
sexually active lives. An effective treatment that 
cures the problem permanently is needed where 
penile revascularization and exercise remain 
treatment options for such patients. However, due 
to the complexity of penile revascularization such 
as cost ineffectiveness, unavailability of experts, 
side effects of surgery and high failure rates 
among the elderly (13) have left people with ED at 
the mercy of exercise. 
 
Although there have been sufficient data on 
the relationship between ED and several well-
recognized risk factors which including aging, 
coronary artery disease, atherosclerosis, diabetes 
mellitus, dyslipidemia, high blood pressure, and 
pelvic surgeries, little attention has been paid by 
the urologists to the role of lifestyle factors in ED. 
However, accumulating data from basic science 
and clinical studies have determined a link 
between the occurrence of ED and a number of 
lifestyle factors, such as smoking, obesity, alcohol 
consumption, and lack of physical activity. The 
application of findings from animal and human 
studies to the clinical practice regarding the 
modification of lifestyle factors could help to 
improve ED as well as reducing the risks of 
developing cardiovascular diseases (14). 
 
Several studies (15-17) have shown an 
inverse relationship between physical activity 
levels and biomarkers of inflammation in both the 
healthy individuals and subjects with 
cardiovascular condition. Studies (18-21) have 
also reported the role of exercise in the 
management of erectile dysfunction. The majority 
of these studies are subjective, retrospective case 
series and non randomized non controlled studies. 
However, randomized controlled trials (RCTs) are 
generally accepted as the most valid method for 
determining the efficacy of a therapeutic 
intervention, because the biases associated with 
other experimental designs can be avoided (22). 
Therefore, the purpose of the present Meta 
analysis study was to determine the role and effect 
of aerobic exercise in the management of erectile 
dysfunction in randomized controlled trials.   
 
MATERIALS AND METHODS 
 
Clinical trials were included if they met all of the 
following inclusion criteria: study population 
defined; Men with arteriogenic ED were 
considered; the present review was concerned with 
studies that used aerobic exercise on ED; only 
randomized controlled trials on this topic were 
selected for review; The main outcome measure 
was satisfactory intercourse without additional 
therapy using the International Index of Erectile 
Dysfunction (IIED) scores. The present review 
utilized studies that had successfully undergone 
rigorous peer review (i.e., published peer-
reviewed journals), were included.  
 
The Medline (Pubmed) electronic database 
was searched (from June 1972 to November 2010) 
for systematic reviews that evaluated the effects of 
therapeutic exercise on ED. The key words and 
search terms used to develop the search strategy 
for each of these databases included: exercise 
therapy, aerobic exercise, therapeutic exercise, 
rehabilitation exercise, impotence and erectile 
dysfunction. In addition, the electronic searches 




were supplemented by checking the reference lists 
of any relevant identified articles. 
 
MEDLINE is the U.S. National Library of 
Medicine's (NLM) premier bibliographic database 
that contains over 18 million references to journal 
articles in life sciences with a concentration on 
biomedicine. A distinctive feature of MEDLINE is 
that the records are indexed with NLM Medical 
Subject Headings (MeSH).The great majority of 
journals are selected for MEDLINE based on the 
recommendation of the Literature Selection 
Technical Review Committee (LSTRC), a 
National Institute of Health (NIH)-chartered 
advisory committee of external experts analogous 
to the committees that review NIH grant 
applications. MEDLINE is the primary component 
of PubMed, part of the entry series of databases 
provided by the NLM National Center for 
Biotechnology Information (NCBI). MEDLINE 
may also be searched via the NLM Gateway (23). 
 
The literature search results were screened, 
and relevant articles were retrieved. Data was 
extracted from each identified paper and included 
information on study design, participants and 
outcome measures. The main outcome was the 
efficacy of treatment for ED compared with 
placebo, sham, or active control in improving ED 
IIED total scores.  
 
In the statistical analysis, the difference 
between the pre-test and post-test values (changed 
score) for IIEF score was computed.  Student t–
test was used to compare the mean changed score 
values of IIEF. All statistical analysis was 
performed on an IBM compatible micro computer 
using SPSS for window version 15.0, (Chicago IL, 
USA). The probability level for all the above tests 




The search criteria identified 210 studies from 
1972 to 2010; on inserting randomized controlled 
trials only 26 studies were identified out of which 
only 5 met the inclusion criteria and 21 studies did 
not meet the inclusion criteria, hence, were 
excluded. Five (18, 24-27) randomized controlled 
trials (RCTs) met the inclusion criteria; studies 
involved the use of aerobic exercise in the 
management of ED, the IIEF was the assessment 
tool for ED and also involved control groups. A 
total of 385 subjects were involved: Lamina et al 
(25), n=43; Lamina et al (26), n=43; Esposito et al 
(18), n= 110; Kalka et al (27), n= 129; Maio, 
Saraed and Marchiori (24), n= 60. 
 
The mean± SD of base line erectile function 
as assessed by the IIEF for the interventions and 
control groups was 13.91±6.37 and 13.26±6.82, 
respectively. There was no group significant 
difference in base line values of EF (t= .158, p= 
.879) at p< 0.05. Detailed mean± SD for pre and 
post intervention are presented on table 1. 
 
Table 1: Pre and posttest International Index of Erectile Function (IIEF) values (mean± SD), (N= 365). 
 
                       Exercise                 Control 
       Pre     Post       Pre       Post 
Variable  mean SD mean SD mean SD mean SD 
IIEF 13.91 6.37 16.7440 5.93661 13.2560 6.82068 13.6160 6.50792 
 
Table 2 showed significant mean effects in 
changed score values between exercise and control 
in all data pooled together (t= 5.856, p= .000) at 
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Evidence from 5 randomized studies published in 
the years between 2004 and 2010, has 
demonstrated strong evidence that aerobic 
exercise can benefit people with arterogenic ED. 
These review results of this study build on and 
update the evidence from studies that concluded 
that concluded that exercise was beneficial for 
people with ED and cardiovascular disorders (25-
27); on ED and obesity (18) and on normal 
subjects with ED (24). However, studies have 
shown common pathway for ED, cardiovascular 
(28 -30) and metabolic disorders (19, 31).  
 
Three of the randomized studies (25-27) that 
contributed to the present study data indicated the 
positive role of both interval and continuous 
aerobic training in the dual management of both 
ED and cardiovascular disorders (hypertension 
and ischemic heart disease ,respectively); this is 
not surprising because of the arterogenic inter-
relationship between ED and several 
cardiovascular disorders. The physiological basis 
for the therapeutic role of continuous exercise in 
the management of both ED and some 
cardiovascular disorders as reported in the present 
study, could be related to the biochemical, neural 
and hormonal changes in the blood vessel walls 
that induce an acute and long-term blood vessel 
relaxation. The blood vessels might relax after 
each exercise session because of body warming 
effects; local production of certain chemicals, such 
lactic acid and NO; decreases in nerve activity; 
and changes in certain hormones and their 
receptors (32, 33). Over time, as the exercise is 
repeated, there appears to be a growing evidence 
of a prolonged effect. Thus, chronic (regular, long-
term) physical training might reduce basal 
concentrations of inflammatory markers. 
Esposito et al (18), in their randomized study 
investigated the effect of physical activities on 110 
obese subjects. They reported significant effect of 
physical activities on both body mass index and 
EF. The physiological rationales underlying this 
hypothesis are that healthy lifestyle factors are 
associated with maintenance of good erectile 
function in men (19); obesity has been positively 
associated with endothelial dysfunction and 
increased serum concentrations of vascular 
inflammatory markers (34, 35); and both 
endothelial and erectile dysfunction may share 
some common metabolic and vascular pathways 
that may be influenced by behavioral-related 
pathways (19, 36). Obese men with erectile 
dysfunction had evidence of abnormal endothelial 
function, which was indicated by reduced blood 
pressure and platelet aggregation responses to L-
arginine and elevated serum concentrations of 
markers of low-grade inflammation, such as IL-6, 
IL-8, and CRP. It has been shown that there are 
significant associations between IEEF score and 
proxy indicators of elevated body fat, the vascular 
response to L-arginine, and circulating IL-8 and 
CRP levels. The association we found between 
IEEF score and indices of endothelial dysfunction 
supports the presence of common vascular 
pathways underlying both conditions in obese 
men. A disturbance in nitric oxide activity linked 
to reduced nitric oxide availability could provide a 
unifying explanation for this association. In 
particular, in isolated corpus cavernosum strips 
from patients with erectile dysfunction both 
neurogenic and endothelium-dependent relaxation 
is impaired (37).  
 
Obesity is a state of chronic oxidative stress 
and inflammation (38). The increased oxidative 
stress associated with obesity may increase free 
radical formation, which could quench and 
deactivate nitric oxide, reducing its availability for 
target cells. Weight loss programs with dietary 
modifications and increased physical activity may 
lead to reduced oxidative stress associated with 




improved nitric oxide availability (39). As 
impaired nitric oxide activity appears to play an 
important role in the pathogenesis of erectile 
dysfunction (40), improved nitric oxide 
availability associated with weight loss may be 
implicated in the amelioration of erectile function 
in our series of obese men. A reduced CRP level 
due to sustained lifestyle changes may have 
contributed to amelioration of erectile function 
after treatment. Levels of CRP correlate 
significantly with reduced nitric oxide availability 
(41) and increasing severity of penile vascular 
disease as measured by penile Doppler (42). 
Moreover, consistent findings support a predictive 
role of CRP and IL-6 for cardiovascular events in 
different populations (43), while IL-8 is a potent 
chemoattractant (44). 
 
Many studies have been conducted on this 
topic; their results have been challenged by lack of 
controlled groups and non-randomization. 
Randomized controlled trials (RCTs) are generally 
accepted as the most valid method for determining 
the efficacy of a therapeutic intervention, because 
the biases associated with other experimental 
designs can be avoided.Non-randomized 
controlled trials, can detect associations between 
an intervention and an outcome. But they cannot 
rule out the possibility that the association was 
caused by a third factor linked to both intervention 
and outcome. Random allocation ensures no 
systematic differences between intervention 
groups in factors, known and unknown, that may 
affect outcome. Randomized controlled trials are 
the most rigorous way of determining whether a 
cause-effect relation exists between treatment and 
outcome and for assessing the cost effectiveness 
of a treatment (45, 22). 
In conclusion, aerobic training can successfully 
treat ED in selected patients with arterogenic ED. 
However, there are very few high-quality 
randomized trials regarding aerobic training and 
ED. Practitioners should bear in mind that aerobic 
training and other risk factors modification is 
associated with higher rates of ED management 
success.Since these results are based on small 
studies, the evidence would be stronger if 
confirmed by large trials. Effectiveness data were 
limited; however, the effectiveness of ED is 
largely determined by the patient health status and 
associated condition. In addition, work is needed 
in the standardization of follow-up protocols, 
evaluation of ED management success and failure, 
patient selection, and statistical analysis. More 
randomized studies that compare various exercise 
techniques are warranted. These studies should 
evaluate efficacy, complications, quality of life, 
cost implications, and long-term outcomes of ED 
management compare to other therapeutic 
modalities available. Also more database search is 
also warranted to further broaden the data search 
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